The START Center for Cancer Research (“START”) is the world’s largest early phase site network, fully dedicated to oncology clinical research. Throughout our history, START has provided hope to cancer patients in global community practices by offering access to cutting edge trials throughout the US and Europe. Today, with over 1,300 studies completed, and with research facilities in the United States and in Spain, Portugal, and Ireland, START’s mission is to accelerate the development of new anticancer drugs that will improve the quality of life and survival for patients with cancer and lead to its eventual cure. To date, over 43 therapies conducted at START locations have obtained FDA/EMA approval. Incredibly, while Academic Medical Centers (AMCs) conduct 80% of cancer trials, such trials reach only 20% of the patient population – leaving the majority of patients who are treated in community practices and hospitals without access to a clinical trial when their care journey calls for one. START serves the many – by bringing cancer trials to physicians and their patients in community hospitals and practices when hope is needed most.
START represents the world’s largest roster of Principal Investigators (PIs) across its eight clinical trial sites. Committed to accelerating passage from trials to treatments, START delivers hope to patients, families, and physicians around the world. As an example, in San Antonio, where START was founded, START treated the first patient ever with Keytruda – the most effective cancer drug in medical history.
Essential Responsibilities
Education & Experience
Physical & Travel Requirements:
Best-in-Class Benefits and Perks
We value our employees’ time and efforts. Our commitment to your success is enhanced by a competitive compensation, depending on experience, and an extensive benefits package including:
More about The START Center for Cancer Research
Deeply rooted in community oncology centers globally, The START Center for Cancer Research provides access to specialized preclinical and early-phase clinical trials of novel anti-cancer agents. START clinical trial sites have conducted more than a thousand early-phase clinical trials, including for 43 therapies that were approved by the FDA. START represents the world’s largest roster of Principal Investigators (PIs) across its eight clinical trial sites. Committed to accelerating passage from trials to treatments, START delivers hope to patients, families, and physicians around the world. Learn more at STARTresearch.com .
...Enterprise Medical Recruiting is assisting one of the largest Pain Management Networks to recruit a new Interventional Pain provider to practice in Lafayette IN. The current setup is 1 MD and 1 APP, but they are looking to grow and add at least another Pain physician....
...including bonus & commission) | Excellent Benefits & Growth Opportunities About Us: Join our dedicated team of professional window cleaning technicians, specializing in both high-rise and low-rise projects. We pride ourselves on delivering top-tier service, ensuring...
-job role Training center teacher or kindergarten teacherSalary: 15k - 20kBonus: Performance-based bonus, attendence bonusOn campus lunch or dinner provided Accommodation allowance: 1k - 2k per month Work Time: 40 hours, 1:30pm -8:30pm/9:00am-5:00pm, two days...
...for a dynamic individual to take on the role of our Mascot Performer and Cow Handler - helping us create remarkable and joyful experiences for guests of all ages at in -store events and community engagements. What You'll Do: As the Cow (Mascot): Step into...
...the most highly respected and successful privately owned commercial real estate brokerage companies in New England. The firm provides the... ...COMMISSION BASED ONLY. The Stubblebine Company/CORFAC International, a high caliber commercial real estate company, has, for over...